Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VEE C-84 Vaccine Booster Safety and Immunogenicity Study
NCT03531242Phase 2Not yet recruiting
- Sponsor
- U.S. Army Medical Research and Development Command
- Start
- Jun 2021
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
Phase 2, open-label trial of Venezuelan equine encephalitis vaccine C-84 in Venezuelan equine encephalomyelitis (VEE), sponsored by U.S. Army Medical Research and Development Command. Planned start Jun 2021; status: not yet recruiting.
02
Drugs
Venezuelan equine encephalitis vaccine C-84
03
Conditions
Venezuelan equine encephalomyelitis (VEE)
Beyond the preview
Go deeper on NCT03531242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03531242.